ExploreWatchlistsPricing
  1. US-listed companies
  2. PTC THERAPEUTICS, INC.
  3. Financials
  4. Stockholders' equity

PTC THERAPEUTICS, INC. (PTCT)

Market cap
$5.9B
P/E ratio
9.2x
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 2025-205-81.30%
Dec 31, 2024-1,098+34.15%
Dec 31, 2023-819+135.84%
Dec 31, 2022-347-24236.72%
Dec 31, 20211-99.70%
Dec 31, 2020482-18.90%
Dec 31, 2019594+69.46%
Dec 31, 2018351+124.20%
Dec 31, 2017156+30.82%
Dec 31, 2016120-47.09%
Dec 31, 2015226-24.28%
Dec 31, 2014298+118.59%
Dec 31, 2013137

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat